Friday, October, 23, 2009
Zetia Cancer
November 17, 2008
Hundreds of heart experts attended a panel discussion at the annual meeting of the American Heart Association to debate the benefits and risks of the cholesterol drugs Vytorin and Zetia. Some cardiologists in the debate tried to calm concerns about the increased cancer risk that's been linked to the drugs, while others urged caution in prescribing the drugs until larger studies are performed on their safety. Vytorin--which is a combination of Zetia and Zocor--was linked to an increased risk of c...
Read more »
Expert & Community Posts
By Gretchen Becker
,
Health Expert
...family has had heart disease and they've all died from cancer at an advanced age, then it would...
Read more »
By Dr. Kang
,
Health Expert
...York Times published an article entitled "Data about Zetia risk was not fully revealed." ...
Read more »
By Dr. Kang
,
Health Expert
...reason that many were suspicious about ezetimibe (Zetia) was that the ENHANCE trial had been...
Read more »
By Dr. William Davis
,
Health Expert
...combination of simvastatin and ezetimibe, brand name Zetia®) vs. just simvastatin. No...
Read more »
By Dr. Kang
,
Health Expert
My mother-in-law has been visiting with us for the past few weeks. She remarked one day while...
Read more »
Health Guide
...rates. In one study, people who took gemfibrozil had higher rates of death from other causes, including
cancer. Some evidence suggests that fibrates may affect receptors involved in
cancer...
Read more »
www.
cancer.gov -- National
Cancer Institutewww.
cancer.org -- American
Cancer Societywww.aacr.org -- American Association for
Cancer Researchwww.asco.org -- American Society of Clinical...
Read more »
www.
cancer.org -- American
Cancer Societywww.
cancer.gov -- National
Cancer Institutewww.oncolink.org -- OncoLink
cancer informationwww.asco.org -- American Society of Clinical...
Read more »
www.
cancer.gov -- National
Cancer Institutewww.
cancer.org -- American
Cancer Societywww.asco.org -- American Society of Clinical Oncologywww.prostate
cancerfoundation.org -- Prostate
Cancer...
Read more »
www.
cancer.gov -- National
Cancer Institutewww.
cancer.org -- American
Cancer Societywww.asco.org -- American Society of Clinical Oncologywww.oncolink.org -- Oncolinkwww.womenshealth.gov --...
Read more »
Related News
October 03, 2008
A new trial on the cholesterol drug Vytorin has produced mixed results that experts say are "troubling." In the study, Vytorin--which is a...
Read summary »
June 19, 2008
(Ivanhoe Newswire) New research sheds light on how a cholesterol drug works in the body. The study is significant because the drug ezetimibe (Zetia)...
Read summary »
September 05, 2008
By Kirsten Houmann, Ivanhoe Health Correspondent ORLANDO, Fla. (Ivanhoe Newswire) -- Those who have had non-melanoma skin cancer may be at...
Read summary »
May 13, 2008
(Ivanhoe Newswire) -- A new study finds taking an aspirin a day may lower a woman's risk for a common type of breast cancer. The study reveals daily...
Read summary »
May 22, 2007
(Ivanhoe Newswire) -- Cancer patients may someday get a boost from a common diabetes drug. New research from Dana-Farber Cancer Institute in Boston...
Read summary »